Medicomply Aps: Financial statements 2024
CVR: 40538399
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Medicomply Aps (CVR 40538399) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 501,586 and a net result of DKK -181,661 compared with DKK 239,249 the year before. That is a decrease of 38.8% compared with the year before. Equity in the 2024 report amounted to DKK 135,591. The solvency ratio was 17.2%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 501,586
- Profit/Loss
- DKK -181,661
- Equity
- DKK 135,591
- Total Assets
- DKK 787,044
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 502K | -182K | 136K | 1 |
| 2023 | - | 819K | 239K | 917K | 1 |
| 2022 | - | 691K | 120K | 604K | 1 |
| 2021 | - | 813K | 262K | 484K | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Medicomply Aps has published its annual report for 2023. Gross profit came to DKK 819,340, and the net result was DKK 239,249.
About Medicomply Aps
Medicomply Aps is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2019. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of John Erik Bech Hansen. The board consists of John Erik Bech Hansen (chair). The company is owned by BECH HOLDING 2007 ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 837,602 and a net result of DKK 170,695 compared with DKK -181,661 the year before. Equity in the 2025 report amounted to DKK 306,286.